Leukotriene Modifiers and Churg-Strauss Syndrome: Adverse Effect or Response to Corticosteroid Withdrawal?

ISSN： 0114-5916

Source： Drug Safety, Vol.21, Iss.4, 1999-10, pp. : 241-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroid withdrawal/montelukast: Churg Strauss syndrome?: case report

Reactions Weekly, Vol. 1, Iss. 1270, 2009-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Leukotriene Receptor Antagonists and Churg-Strauss Syndrome: Cause, Trigger or Merely an Association?

By Keogh Karina A.

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 837-843

Adis International

Access to resources Recommend Favorite

Omalizumab: Churg-Strauss syndrome following corticosteroid withdrawal: case report

Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Montelukast: Churg-Strauss syndrome: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Treating Asthma in the Older Patient: Is There a Place for Leukotriene Modifiers?

By Grayson Mitchell H. Korenblat Phillip E.

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite